Susquehanna International Group, LLP Ptc Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 22,142 shares of PTCT stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,142

Previous 16,185 36.81%

Holding current value

$1.02 Million

Previous $494,000 66.19%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.39 - $37.66 $181,033 - $224,340	5,957 Added 36.81%	22,142 $821,000
Q2 2024 Aug 15, 2024	SELL	$24.69 - $40.12 $919,677 - $1.49 Million	-37,249 Reduced 69.71%	16,185 $494,000
Q1 2024 May 07, 2024	BUY	$24.15 - $31.95 $699,577 - $925,527	28,968 Added 118.4%	53,434 $1.55 Million
Q4 2023 Feb 14, 2024	SELL	$18.07 - $29.37 $1.32 Million - $2.14 Million	-72,996 Reduced 74.9%	24,466 $674,000
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $388,679 - $728,274	-17,344 Reduced 15.11%	97,462 $2.18 Million
Q2 2023 Aug 11, 2023	SELL	$40.4 - $59.1 $304,737 - $445,791	-7,543 Reduced 6.17%	114,806 $4.67 Million
Q1 2023 May 16, 2023	BUY	$38.16 - $48.86 $3.03 Million - $3.87 Million	79,274 Added 184.04%	122,349 $5.93 Million
Q4 2022 Feb 14, 2023	SELL	$33.53 - $54.79 $936,526 - $1.53 Million	-27,931 Reduced 39.34%	43,075 $1.64 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $745,306 - $959,014	17,809 Added 33.48%	71,006 $3.57 Million
Q2 2022 Aug 15, 2022	BUY	$25.6 - $45.23 $318,643 - $562,977	12,447 Added 30.54%	53,197 $2.13 Million
Q1 2022 May 16, 2022	SELL	$33.33 - $44.6 $535,779 - $716,945	-16,075 Reduced 28.29%	40,750 $1.52 Million
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $107,352 - $127,086	3,036 Added 5.64%	56,825 $2.26 Million
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $634,388 - $766,888	17,141 Added 46.77%	53,789 $2 Million
Q2 2021 Aug 11, 2021	SELL	$37.95 - $49.37 $209,294 - $272,275	-5,515 Reduced 13.08%	36,648 $1.55 Million
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $1.34 Million - $1.97 Million	28,634 Added 211.65%	42,163 $2 Million
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $203,206 - $286,590	-4,237 Reduced 23.85%	13,529 $826,000
Q3 2020 Nov 16, 2020	BUY	$45.41 - $57.07 $6,448 - $8,103	142 Added 0.81%	17,766 $830,000
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $2.08 Million - $2.68 Million	-48,771 Reduced 73.46%	17,624 $894,000
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $927,853 - $1.7 Million	28,664 Added 75.97%	66,395 $2.96 Million
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $349,191 - $497,355	-10,325 Reduced 21.49%	37,731 $1.28 Million
Q2 2019 Aug 16, 2019	BUY	$35.42 - $45.0 $1.38 Million - $1.76 Million	39,046 Added 433.36%	48,056 $2.16 Million
Q2 2018 Aug 14, 2018	SELL	$25.7 - $47.88 $6.58 Million - $12.3 Million	-256,041 Reduced 96.6%	9,010 $304,000
Q4 2017 Feb 14, 2018	BUY	$15.14 - $20.89 $1.92 Million - $2.65 Million	127,081 Added 92.11%	265,051 $4.42 Million
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $2.32 Million - $2.98 Million	137,970	137,970 $2.76 Million

Others Institutions Holding PTCT

# of Institutions

221

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Ptc Therapeutics, Inc. Transaction History